ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT05225961

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (from the registry)
Registry
  • NCT NCT05225961
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05225961. Randomized; single masking; primary purpose treatment. Start 2026-03-20 (actual); primary completion 2026-03-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
Acronym
ATILA
Condition
Acute Ischemic Stroke
Intervention (Drug)
Tirofiban
Intervention (Drug)
Acetylsalicylic acid
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (class: other)

Record details

Record id
cardio:ct-nct05225961
Content hash
5b21418d97f6c0395d8e7d8543f9ebb969633d44742045cb0c01112bf7273fe3